EU Cancer Screening 30 Years On: Investment, Co-operation And Opportunity
This article was originally published in Clinica
Executive Summary
The demand for cancer screening in Europe is growing and the latest statistics from the European Commission show that over 500 million screening examinations for breast, cervical and colorectal cancers will have been undertaken in publicly mandated programs between 2010 and 2020.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.